Evidence map›Paper›PMID 41516431›Full record

ArticleInternational journal of molecular sciences2025

Correction: Tosic et al. High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia.

Natasa Tosic, Kristina Tomic Vujovic, Vojin Vukovic, Nikola Kotur, Biljana Stankovic, Irena Marjanovic, Darko Antic, Sofija Sarac, Tamara Bibic, Jelena Ivanovic and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Natasa TosicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.ORCID 0000-0002-1293-6215
Kristina Tomic VujovicClinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0009-0001-1573-570X
Vojin VukovicClinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Nikola KoturInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.ORCID 0000-0002-9440-9258
Biljana StankovicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.ORCID 0000-0002-7571-277X
Irena MarjanovicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.ORCID 0000-0001-9102-5251
Darko AnticClinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0000-0002-2608-1342
Sofija SaracClinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.
Tamara BibicClinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0009-0000-2453-3213
Jelena IvanovicClinic for Hematology, University Clinical Center of Serbia, 11000 Belgrade, Serbia.ORCID 0009-0009-2251-3011
Branka ZukicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.
Teodora Karan-DjurasevicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The following references [24,26] have been retracted and should be removed from the original publication [...].

Identifiers

PMID41516431
PMCPMC12786028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.